The growing complexity of pharmaceutical and biotech innovation has placed unprecedented pressure on life science recruiters ...

As 2026 begins, we find ourselves reflecting on the dynamic landscape of Life Sciences and Healthcare regulations over the ...

Over the past four years, private equity (PE) firms that invested in life science assets have faced a difficult reality. While many investors still debate whether some sectors of the market are in a ...